ALECTINIB
alectinib 150 mg capsule, 4 x 56
ALECTINIB (15376G)
15376G
Manner of administration:Oral
Restriction
Indication: Resected non-small cell lung cancer (NSCLC)
Treatment phase: Adjuvant therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 224 | # of repeats: 3 | DPMQ: $6,579.20 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Alecensa | |||||